GB202406990D0 - T cell receptors and uses thereof - Google Patents
T cell receptors and uses thereofInfo
- Publication number
- GB202406990D0 GB202406990D0 GBGB2406990.8A GB202406990A GB202406990D0 GB 202406990 D0 GB202406990 D0 GB 202406990D0 GB 202406990 A GB202406990 A GB 202406990A GB 202406990 D0 GB202406990 D0 GB 202406990D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cell receptors
- receptors
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
- A61K40/32—T-cell receptors [TCR]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/4242—Transcription factors, e.g. SOX or c-MYC
- A61K40/4243—Wilms tumor 1 [WT1]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2406990.8A GB202406990D0 (en) | 2024-05-16 | 2024-05-16 | T cell receptors and uses thereof |
| PCT/GB2025/051048 WO2025238364A1 (en) | 2024-05-16 | 2025-05-15 | T cell receptors specific for hla-e restricted wt1 peptide and uses thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2406990.8A GB202406990D0 (en) | 2024-05-16 | 2024-05-16 | T cell receptors and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202406990D0 true GB202406990D0 (en) | 2024-07-03 |
Family
ID=92932178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2406990.8A Ceased GB202406990D0 (en) | 2024-05-16 | 2024-05-16 | T cell receptors and uses thereof |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB202406990D0 (en) |
| WO (1) | WO2025238364A1 (en) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ531208A (en) | 2001-08-31 | 2005-08-26 | Avidex Ltd | Multivalent soluble T cell receptor (TCR) complexes |
| EP3447140A3 (en) * | 2011-06-28 | 2019-05-29 | International Institute of Cancer Immunology, Inc. | Receptor gene for peptide cancer antigen-specific t cell |
| WO2016022400A1 (en) * | 2014-08-04 | 2016-02-11 | Fred Hutchinson Cancer Research Center | T cell immunotherapy specific for wt-1 |
| CN114206385A (en) * | 2019-06-07 | 2022-03-18 | 俄勒冈健康与科学大学 | Tumor associated antigen specific T cell responses |
| CA3147717A1 (en) * | 2019-08-20 | 2021-02-25 | Fred Hutchinson Cancer Research Center | T-cell immunotherapy specific for wt-1 |
| GB202019019D0 (en) * | 2020-12-02 | 2021-01-13 | Univ Oxford Innovation Ltd | T cell receptors and uses thereof |
| NL2031118B1 (en) * | 2022-03-01 | 2023-09-07 | Academisch Ziekenhuis Leiden | T cell receptors directed against transcription factor wt1 and uses thereof |
-
2024
- 2024-05-16 GB GBGB2406990.8A patent/GB202406990D0/en not_active Ceased
-
2025
- 2025-05-15 WO PCT/GB2025/051048 patent/WO2025238364A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025238364A1 (en) | 2025-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4123746A4 (en) | Solid electrolyte material and cell using same | |
| GB202019019D0 (en) | T cell receptors and uses thereof | |
| GB202214325D0 (en) | Electrode and electrochemical cell | |
| IL276599A (en) | Mage-a1 specific t cell receptor and uses thereof | |
| GB202504541D0 (en) | T cell receptors and uses thereof | |
| GB202417350D0 (en) | T cell receptors and uses thereof | |
| GB202406990D0 (en) | T cell receptors and uses thereof | |
| GB202114064D0 (en) | Electrochemical cell and electrode | |
| GB202313889D0 (en) | Electrode and electrochemical cell | |
| GB202418303D0 (en) | T cell receptors | |
| GB202417085D0 (en) | Electrolutic cells and their use | |
| AU2021903994A0 (en) | Modified T cell receptors and uses thereof | |
| IL321325A (en) | T cell receptor constructs and uses thereof | |
| GB202303470D0 (en) | Electrode and elctrochemical cell | |
| GB202405657D0 (en) | T cell receptor identification and provision | |
| GB201915367D0 (en) | T cell receptors and modified t cells | |
| IL321647A (en) | Engineered t cell receptors and engineered immune cells expressing the same | |
| GB202417871D0 (en) | Cell | |
| GB202402745D0 (en) | Cell | |
| GB202511276D0 (en) | Cell unit and cell stack | |
| GB202303469D0 (en) | Electrode and electrochemical cell | |
| AU2023903520A0 (en) | Electrochemical cell and uses thereof | |
| AU2022903706A0 (en) | Electrochemical cell and uses thereof | |
| GB202404177D0 (en) | Cell line | |
| GB202114065D0 (en) | Electrode and electrochemical cell |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |